Timing and Management of Surgical Site Infections in Patients With Open Fracture Wounds: A Fluid Lavage of Open Wounds Cohort Secondary Analysis.


Journal

Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705

Informations de publication

Date de publication:
01 03 2021
Historique:
accepted: 28 07 2020
pubmed: 27 10 2020
medline: 22 6 2021
entrez: 26 10 2020
Statut: ppublish

Résumé

Many studies report on the incidence or prevalence of fracture-related surgical site infections (SSIs) after open fractures; however, few studies report on their timing and management outcomes. To address this gap, we used data from the Fluid Lavage of Open Wounds trial to determine timing of diagnosis, management, and resolution of SSIs. All participants included in this analysis had an SSI after an open fracture. Participants were assigned to a group based on the type of SSI as follows: (1) those who developed a superficial SSI and (2) those who had either a deep or organ/space SSI. Descriptive statistics characterized the type, timing, and management of each SSI. Of the 2445 participants in the Fluid Lavage of Open Wounds trial, 325 (13.3%) had an SSI. Superficial SSIs were diagnosed significantly earlier [26.5 days, interquartile range (IQR) 12-48] than deep or organ/space SSIs (53 days, IQR 15-119). Of the 325 patients with SSIs, 174 required operative management and 151 were treated nonoperatively. For SSIs managed operatively, median time for infection resolution was 73 days (IQR 28-165), and on average, 1.73 surgeries (95% confidence interval 1.58-1.88) were needed during the 12 months follow-up. There were 24 cases whose SSIs were not resolved at the time of the final follow-up visit (12 months). Based on this study's findings and in contradistinction to the Centers for Disease Control and Prevention guidelines, after an open fracture, superficial SSIs were diagnosed at one month and deep/organ/space SSIs at 2 months. This information can allow for earlier infection detection. In addition, the knowledge that approximately 50% of the SSIs in our study required a reoperation and 3 months at a minimum to resolve will assist orthopaedic surgeons when counseling their patients. Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Sections du résumé

BACKGROUND
Many studies report on the incidence or prevalence of fracture-related surgical site infections (SSIs) after open fractures; however, few studies report on their timing and management outcomes. To address this gap, we used data from the Fluid Lavage of Open Wounds trial to determine timing of diagnosis, management, and resolution of SSIs.
METHODS
All participants included in this analysis had an SSI after an open fracture. Participants were assigned to a group based on the type of SSI as follows: (1) those who developed a superficial SSI and (2) those who had either a deep or organ/space SSI. Descriptive statistics characterized the type, timing, and management of each SSI.
RESULTS
Of the 2445 participants in the Fluid Lavage of Open Wounds trial, 325 (13.3%) had an SSI. Superficial SSIs were diagnosed significantly earlier [26.5 days, interquartile range (IQR) 12-48] than deep or organ/space SSIs (53 days, IQR 15-119). Of the 325 patients with SSIs, 174 required operative management and 151 were treated nonoperatively. For SSIs managed operatively, median time for infection resolution was 73 days (IQR 28-165), and on average, 1.73 surgeries (95% confidence interval 1.58-1.88) were needed during the 12 months follow-up. There were 24 cases whose SSIs were not resolved at the time of the final follow-up visit (12 months).
CONCLUSIONS
Based on this study's findings and in contradistinction to the Centers for Disease Control and Prevention guidelines, after an open fracture, superficial SSIs were diagnosed at one month and deep/organ/space SSIs at 2 months. This information can allow for earlier infection detection. In addition, the knowledge that approximately 50% of the SSIs in our study required a reoperation and 3 months at a minimum to resolve will assist orthopaedic surgeons when counseling their patients.
LEVEL OF EVIDENCE
Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 33105456
pii: 00005131-202103000-00005
doi: 10.1097/BOT.0000000000001912
doi:

Banques de données

ClinicalTrials.gov
['NCT00788398']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-135

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflict of interest.

Références

Parker B, Petrou S, Achana F, et al. Economic outcomes associated with deep surgical site infection in patients with an open fracture of the lower limb. Bone Joint J. 2018;100B:1506–1510.
Doshi P, Gopalan H, Sprague S, et al. Incidence of infection following internal fixation of open and closed tibia fractures in India (INFINITI): a multi-centre observational cohort study. BMC Musculoskelet Disord. 2017;18:156–210.
Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–189.
Gustilo RB, Anderson J. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453–458.
Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24:742–746.
Gustilo RB, Gruninger RP, Davis T. Classification of type III (severe) open fractures relative to treatment and results. Orthopedics. 1987;10:1781–1788.
Patzakis MJ, Harvey JP, Ivler D. The role of antibiotics in the management of open fractures. J Bone Joint Surg Am. 1974;56:532–541.
Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989:36–40.
Redfern J, Wasilko SM, Groth ME, et al. Surgical site infections in patients with type 3 open fractures. J Orthop Trauma. 2016;30:415–419.
Hu R, Ren Y-J, Yan L, et al. Analysis of staged treatment for Gustilo–Anderson IIIB/C open tibial fractures. Indian J Orthop. 2018;52:411–417.
Aytaç S, Schnetzke M, Swartman B, et al. Posttraumatic and postoperative osteomyelitis: surgical revision strategy with persisting fistula. Arch Orthop Trauma Surg. 2014;134:159–165.
Ren M, Liang W, Wu Z, et al. Risk factors of surgical site infection in geriatric orthopedic surgery: a retrospective multicenter cohort study. Geriatr Gerontol Int. 2019;19:213–217.
Chen AT, Vallier HA. Noncontiguous and open fractures of the lower extremity: epidemiology, complications, and unplanned procedures. Injury. 2016;47:742–747.
FLOW Investigators, Bhandari M, Bhandari M, Jeray KJ, et al. A trial of wound irrigation in the initial management of open fracture wounds. N Engl J Med. 2015;373:2629–2641.
Centers for Disease Control and Prevention (CDC). Surgical Site Infection (SSI) Event. 2017. Available at: https://www.cdc.gov .
Leaper D, Fry DE, Assadian O. Perspectives in prevention and treatment of surgical site infection—a narrative review of the literature. Wounds. 2013;25:313–323.
Oliveira PR, Carvalho VC, da Silva Felix C, et al. The incidence and microbiological profile of surgical site infections following internal fixation of closed and open fractures. Rev Bras Ortop. 2016;51:396–399.
Control Centre for Disease. Procedure-associated Module SSI Surgical. 2019:20–31. Available at: https://www.cdc.gov .
Metsemakers WJ, Kortram K, Morgenstern M, et al. Definition of infection after fracture fixation: a systematic review of randomized controlled trials to evaluate current practice. Injury. 2018;49:497–504.
Prada C, Tanner SL, Marcano-Fernández FA, et al. How successful is antibiotic treatment for superficial surgical site infections after open fracture? A Fluid Lavage of Open Wounds (flow) cohort secondary analysis. Clin Orthop Relat Res. 2020.

Auteurs

Carlos Prada (C)

Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.

Francesc A Marcano-Fernández (FA)

Orthopaedic Department, Parc Taulí Hospital Universitari, Institut D'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.

Emil H Schemitsch (EH)

Department of Surgery, University of Western Ontario, London, ON, Canada.

Sofia Bzovsky (S)

Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.

Kyle Jeray (K)

Department of Orthopaedic Surgery, Greenville Health System, Greenville, SC; and.

Brad Petrisor (B)

Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.

Mohit Bhandari (M)

Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Sheila Sprague (S)

Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH